Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DHX9 |
| Upstream (Parents) |
|---|
| (<<) BAD → DHX9 |
| (<<) JUNB → DHX9 |
| (<<) MCL1 → DHX9 |
| (<<) RHOG → DHX9 |
| (<<) RRAS → DHX9 |
| Downstream (Children) |
|---|
| DHX9 → ADAM10 (>>) |
| DHX9 → AKT1 (>>) |
| DHX9 → ATP2B4 (>>) |
| DHX9 → CASP2 (>>) |
| DHX9 → CASP8 (>>) |
| DHX9 → CPD (>>) |
| DHX9 → CRK (>>) |
| DHX9 → CRKL (>>) |
| DHX9 → DOCK9 (>>) |
| DHX9 → EML4 (>>) |
| DHX9 → FOXO3 (>>) |
| DHX9 → GNA13 (>>) |
| DHX9 → HSPA4 (>>) |
| DHX9 → ITCH (>>) |
| DHX9 → ITGB8 (>>) |
| DHX9 → MAP3K11 (>>) |
| DHX9 → MAP3K2 (>>) |
| DHX9 → MAPK1 (>>) |
| DHX9 → NCOA3 (>>) |
| DHX9 → NRAS (>>) |
| DHX9 → PIK3CB (>>) |
| DHX9 → PRPF4B (>>) |
| DHX9 → RAB5A (>>) |
| DHX9 → RB1 (>>) |
| DHX9 → SMAD5 (>>) |
| DHX9 → STAM2 (>>) |
| DHX9 → STAT1 (>>) |
| DHX9 → THBS1 (>>) |
| DHX9 → TXNIP (>>) |
